199 related articles for article (PubMed ID: 29318692)
1. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
[TBL] [Abstract][Full Text] [Related]
2. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
3. JK1 (FAM134B) gene and colorectal cancer: a pilot study on the gene copy number alterations and correlations with clinicopathological parameters.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Mol Pathol; 2014 Aug; 97(1):31-6. PubMed ID: 24825067
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor.
Islam F; Gopalan V; Vider J; Wahab R; Ebrahimi F; Lu CT; Kasem K; Lam AKY
Exp Cell Res; 2017 Aug; 357(2):260-270. PubMed ID: 28549913
[TBL] [Abstract][Full Text] [Related]
5. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
6. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of methylation of CpG island in cystathionine beta synthase promoter and clinicopathological features in colorectal cancer].
Tu XH; Huang SX; Li WS; Song JX
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):351-5. PubMed ID: 24054011
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.
Lo PK; Lee JS; Chen H; Reisman D; Berger FG; Sukumar S
Exp Mol Pathol; 2013 Feb; 94(1):262-9. PubMed ID: 23103611
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
10. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
11. CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients.
Harder J; Engelstaedter V; Usadel H; Lassmann S; Werner M; Baier P; Otto F; Varbanova M; Schaeffner E; Olschewski M; Blum HE; Opitz OG
Br J Cancer; 2009 Jan; 100(2):360-5. PubMed ID: 19142184
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
13. Novel FAM134B mutations and their clinicopathological significance in colorectal cancer.
Islam F; Gopalan V; Wahab R; Lee KT; Haque MH; Mamoori A; Lu CT; Smith RA; Lam AK
Hum Genet; 2017 Mar; 136(3):321-337. PubMed ID: 28144752
[TBL] [Abstract][Full Text] [Related]
14. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
[TBL] [Abstract][Full Text] [Related]
15. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.
Chen SQ; Chen ZH; Lin SY; Dai QB; Fu LX; Chen RQ
World J Gastroenterol; 2014 Aug; 20(29):10071-81. PubMed ID: 25110434
[TBL] [Abstract][Full Text] [Related]
16. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
19. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
Qi J; Zhu YQ; Luo J; Tao WH
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1954-7. PubMed ID: 17923031
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]